BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34007770)

  • 1. The Gut Microbiome and Cardiovascular Disease.
    Astudillo AA; Mayrovitz HN
    Cureus; 2021 Apr; 13(4):e14519. PubMed ID: 34007770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis.
    Manolis AA; Manolis TA; Melita H; Manolis AS
    Curr Med Chem; 2022; 29(23):4050-4077. PubMed ID: 34961453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiome and cardiovascular disease: current knowledge and clinical potential.
    Ahmad AF; Dwivedi G; O'Gara F; Caparros-Martin J; Ward NC
    Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H923-H938. PubMed ID: 31469291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?
    He M; Tan CP; Xu YJ; Liu Y
    Food Res Int; 2020 Dec; 138(Pt B):109812. PubMed ID: 33288187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome and its role in cardiovascular diseases.
    Ahmadmehrabi S; Tang WHW
    Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota derived metabolites in cardiovascular health and disease.
    Wang Z; Zhao Y
    Protein Cell; 2018 May; 9(5):416-431. PubMed ID: 29725935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut-immune axis during hypertension and cardiovascular diseases.
    Dinakis E; O'Donnell JA; Marques FZ
    Acta Physiol (Oxf); 2024 Jun; ():e14193. PubMed ID: 38899764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
    Romano KA; Vivas EI; Amador-Noguez D; Rey FE
    mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases.
    Garg Y; Kanwar N; Chopra S; Tambuwala MM; Dodiya H; Bhatia A; Kanwal A
    Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1344-1356. PubMed ID: 35761484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of gut microbiome on coronary artery disease.
    Xu J; Yang Y
    Cardiovasc Diagn Ther; 2020 Aug; 10(4):869-880. PubMed ID: 32968642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and its Therapeutic Implications.
    Liu L; Kaur GI; Kumar A; Kanwal A; Singh SP
    Cardiovasc Hematol Agents Med Chem; 2024 Jan; ():. PubMed ID: 38275032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of TMAO-producer phenotype and host-diet-gut dysbiosis by carnitine challenge test in human and germ-free mice.
    Wu WK; Chen CC; Liu PY; Panyod S; Liao BY; Chen PC; Kao HL; Kuo HC; Kuo CH; Chiu THT; Chen RA; Chuang HL; Huang YT; Zou HB; Hsu CC; Chang TY; Lin CL; Ho CT; Yu HT; Sheen LY; Wu MS
    Gut; 2019 Aug; 68(8):1439-1449. PubMed ID: 30377191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Heart, Vascular Injury.
    Zeng C; Tan H
    Adv Exp Med Biol; 2020; 1238():107-141. PubMed ID: 32323183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.
    Usman I; Anwar A; Shukla S; Pathak P
    Cardiovasc Hematol Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38879769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.
    Kasselman LJ; Vernice NA; DeLeon J; Reiss AB
    Atherosclerosis; 2018 Apr; 271():203-213. PubMed ID: 29524863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between gut microbiome and cardiovascular disease.
    Peng J; Xiao X; Hu M; Zhang X
    Life Sci; 2018 Dec; 214():153-157. PubMed ID: 30385177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-
    Cho CE; Aardema NDJ; Bunnell ML; Larson DP; Aguilar SS; Bergeson JR; Malysheva OV; Caudill MA; Lefevre M
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiome, Functional Food, Atherosclerosis, and Vascular Calcifications-Is There a Missing Link?
    Cretoiu D; Ionescu RF; Enache RM; Cretoiu SM; Voinea SC
    Microorganisms; 2021 Sep; 9(9):. PubMed ID: 34576810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding connections and roles of gut microbiome in cardiovascular diseases.
    Rajendiran E; Ramadass B; Ramprasath V
    Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota in Vascular Disease: Therapeutic Target?
    Anbazhagan AN; Priyamvada S; Priyadarshini M
    Curr Vasc Pharmacol; 2017; 15(4):291-295. PubMed ID: 28056754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.